JAMA Oncology Author Interviews
by JAMA NetworkInterviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.
Copyright: American Medical Association, 2020
Episodes
Comparison of Vaginal Testosterone Cream or Vaginal Ring
17m · PublishedInterview with Michelle E. Melisko, MD, author of Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer: A Randomized Clinical Trial
Association Between Androgen Deprivation Therapy and Risk of Dementia
5m · PublishedInterview with Kevin T. Nead, MD, MPhil, author of Association Between Androgen Deprivation Therapy and Risk of Dementia
Adjuvant Endocrine Therapy and Risk of Contralateral Breast Cancer
3m · PublishedInterview with Gretchen L. Gierach, PhD, author of Association of Adjuvant Tamoxifen and Aromatase Inhibitor Therapy With Contralateral Breast Cancer Risk Among US Women With Breast Cancer in a General Community Setting
Prognostic Factors for Local Control in Breast Cancer With Boost vs No Boost
7m · PublishedInterview with Conny Vrieling, MD PhD, author of Prognostic Factors For Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial
ESR1 Mutations in Metastatic Breast Cancer
6m · PublishedInterview with Sarat Chandarlapaty, MD, PhD, author of Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial
Outcomes for Biomarker-Based Treatment Strategies in Refractory Malignant Neoplasms
6m · PublishedInterview with Razelle Kurzrock, MD, author of Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms: A Meta-analysis
Physiologic Frailty in Hematopoietic Cell Transplantation Patients
5m · PublishedInterview with Smita Bhatia, MD, MPH, author of Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor Study
Lifestyle Associations With US Cancer Incidence and Mortality
7m · PublishedInterview with Mingyang Song, MD, ScD, author of Preventable Incidence and Mortality of Carcinoma Associated With Lifestyle Factors Among Whites in the United States
Neratinib vs Trastuzumab for Untreated Metastatic ERBB2-Positive Breast Cancer
17m · PublishedInterview with Ahmad Awada, MD, PhD, author of Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial, and Mark D. Pegram, MD, author of Neratinib in ERBB2-Positive Brain Metastases
Prostate-Specific Antigen Screening and Selective Treatment
10m · PublishedInterview with Ruth Etzioni, PhD, author of Economic Analysis of Prostate-Specific Antigen Screening and Selective Treatment Strategies, and Andrew J. Vickers, PhD, author of Does Prostate-Specific Antigen Screening Do More Good Than Harm? Depends on How You Do It
JAMA Oncology Author Interviews has 114 episodes in total of non- explicit content. Total playtime is 26:41:12. The language of the podcast is English. This podcast has been added on November 27th 2022. It might contain more episodes than the ones shown here. It was last updated on May 21st, 2024 23:45.
